Proprotein convertase subtilisin/kexin type 9 inhibitors in half of all patients after acute coronary syndrome? Maybe not

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	57-58
Number of pages	2
Journal	European journal of preventive cardiology
Volume	28
Issue number	1
DOIs	https://doi.org/10.1093/eurjpc/zwaa018
Publication status	Published - 1 Jan 2021

Access to Document

@article{a62775c3e2834a31ab4c485c5afd71af,

title = "Proprotein convertase subtilisin/kexin type 9 inhibitors in half of all patients after acute coronary syndrome? Maybe not",

author = "Yvo Smulders",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2021",

month = jan,

day = "1",

doi = "https://doi.org/10.1093/eurjpc/zwaa018",

language = "English",

volume = "28",

pages = "57--58",

journal = "European journal of preventive cardiology",

issn = "2047-4873",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Proprotein convertase subtilisin/kexin type 9 inhibitors in half of all patients after acute coronary syndrome? Maybe not

AU - Smulders, Yvo

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2021/1/1

Y1 - 2021/1/1

UR - http://www.scopus.com/inward/record.url?scp=85103474339&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/eurjpc/zwaa018

DO - https://doi.org/10.1093/eurjpc/zwaa018

M3 - Editorial

C2 - 33624051

SN - 2047-4873

VL - 28

SP - 57

EP - 58

JO - European journal of preventive cardiology

JF - European journal of preventive cardiology

IS - 1

ER -